|
The latest Mainline newsletters for the General Public are listed here. |
For healthcare professionals we have a Mainline newsletter in a Professional version here. |
Mainline |
||
| Volume 2 | September 9, 2005 | Number6 |
An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service |
||
Medication News & Update
Fentanyl caution (Duragesic) - FDA has sent out an alert cautioning helathcare prescribers about assuring that their patients utilizxe this drug exactly as outlined in the monograoh because of increased mortality rates. Use the lowest effective dose and use only in patients previously treated with opiods. Do not use for short term pain management or after surgery. Be sure to advise patients that drug absorption may increase with fever or increase heat exposure.
PSA & Obesity - Past studies have reported an increase risk of prostate cancer in in obese patients. Other studies show little or no association to obesity. It is now thought that obesity may actually result in artificially decreased PSA levels. This would make it difficlut for physicians to diagnose prostate cancer because of the suppression of PSA values in obese patients. For further details refer to Cancer 2005; 103: 1092-5.
|
[ Home ]
[ About Us ]
[ Assessment Tools ]
[ Sample Consult ] |
